This new CHIPS platform provides a crucial technological bridge between foundational FRESH™ 3D bioprinting capabilities and ...

In a lawsuit filed Thursday in a New Jersey federal court, Halozyme alleges that a proposed subcutaneous formulation of Merck’s popular cancer drug Keytruda infringes 15 of its patents.

Micro decisions can have macro consequences. A soft matter physicist reveals how interactions within simple cellular ...

Opdivo Qvantig and Tecentriq Hybreza both rely on Halozyme's hyaluronidase technology, which temporarily hydrolyses hyaluronan in the extracellular matrix of the subcutaneous layer of skin ...

A fire damaged a home in the Toro Park neighborhood of Monterey County earlier today, but fortunately, no one was home, and officials responded quickly.The fire occurred on Capote Drive, just off ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year.

WE wish to suggest a structure for the salt of deoxyribose nucleic acid (D.N.A.). This structure has novel features which are of considerable biological interest. A structure for nucleic acid has ...